nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—Furosemide—dilated cardiomyopathy	0.538	1	CbGbCtD
Baclofen—GABBR2—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.0249	0.136	CbGpPWpGaD
Baclofen—Bladder spasm—Furosemide—dilated cardiomyopathy	0.0244	0.0874	CcSEcCtD
Baclofen—GABBR1—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.016	0.0878	CbGpPWpGaD
Baclofen—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0159	0.0869	CbGpPWpGaD
Baclofen—GABBR2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00983	0.0538	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00714	0.0391	CbGpPWpGaD
Baclofen—GABBR1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00633	0.0347	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00537	0.0294	CbGpPWpGaD
Baclofen—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00475	0.017	CcSEcCtD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0046	0.0252	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00429	0.0235	CbGpPWpGaD
Baclofen—Lethargy—Spironolactone—dilated cardiomyopathy	0.00416	0.0149	CcSEcCtD
Baclofen—GABBR2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00411	0.0225	CbGpPWpGaD
Baclofen—Ataxia—Spironolactone—dilated cardiomyopathy	0.00384	0.0138	CcSEcCtD
Baclofen—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00381	0.0136	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00346	0.019	CbGpPWpGaD
Baclofen—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00325	0.0116	CcSEcCtD
Baclofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00318	0.0174	CbGpPWpGaD
Baclofen—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00315	0.0113	CcSEcCtD
Baclofen—Renal failure—Spironolactone—dilated cardiomyopathy	0.00309	0.0111	CcSEcCtD
Baclofen—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00292	0.0105	CcSEcCtD
Baclofen—GABBR2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00286	0.0157	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00286	0.0157	CbGpPWpGaD
Baclofen—Bladder pain—Furosemide—dilated cardiomyopathy	0.00277	0.00991	CcSEcCtD
Baclofen—GABBR1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00276	0.0151	CbGpPWpGaD
Baclofen—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00274	0.00981	CcSEcCtD
Baclofen—GABBR2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00266	0.0146	CbGpPWpGaD
Baclofen—Mental disability—Furosemide—dilated cardiomyopathy	0.00265	0.00951	CcSEcCtD
Baclofen—GABBR1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00265	0.0145	CbGpPWpGaD
Baclofen—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00259	0.0093	CcSEcCtD
Baclofen—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00259	0.0093	CcSEcCtD
Baclofen—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00256	0.00919	CcSEcCtD
Baclofen—Swelling—Furosemide—dilated cardiomyopathy	0.00252	0.00902	CcSEcCtD
Baclofen—Alopecia—Spironolactone—dilated cardiomyopathy	0.00249	0.00894	CcSEcCtD
Baclofen—Oliguria—Lisinopril—dilated cardiomyopathy	0.00249	0.00893	CcSEcCtD
Baclofen—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00244	0.00875	CcSEcCtD
Baclofen—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.0023	0.00823	CcSEcCtD
Baclofen—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00228	0.00817	CcSEcCtD
Baclofen—Lethargy—Furosemide—dilated cardiomyopathy	0.00227	0.00812	CcSEcCtD
Baclofen—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00223	0.00799	CcSEcCtD
Baclofen—Malaise—Spironolactone—dilated cardiomyopathy	0.00222	0.00794	CcSEcCtD
Baclofen—Photophobia—Lisinopril—dilated cardiomyopathy	0.00215	0.00772	CcSEcCtD
Baclofen—Urinary retention—Furosemide—dilated cardiomyopathy	0.00211	0.00757	CcSEcCtD
Baclofen—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00208	0.00744	CcSEcCtD
Baclofen—Discomfort—Spironolactone—dilated cardiomyopathy	0.00207	0.00741	CcSEcCtD
Baclofen—Dehydration—Furosemide—dilated cardiomyopathy	0.00206	0.0074	CcSEcCtD
Baclofen—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00205	0.00736	CcSEcCtD
Baclofen—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00203	0.00727	CcSEcCtD
Baclofen—Confusional state—Spironolactone—dilated cardiomyopathy	0.00202	0.00725	CcSEcCtD
Baclofen—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00201	0.00721	CcSEcCtD
Baclofen—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00196	0.00702	CcSEcCtD
Baclofen—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00191	0.00683	CcSEcCtD
Baclofen—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00188	0.00674	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00184	0.0101	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00184	0.0101	CbGpPWpGaD
Baclofen—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00183	0.00655	CcSEcCtD
Baclofen—Injury—Lisinopril—dilated cardiomyopathy	0.00181	0.0065	CcSEcCtD
Baclofen—Somnolence—Spironolactone—dilated cardiomyopathy	0.00178	0.00639	CcSEcCtD
Baclofen—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00177	0.00635	CcSEcCtD
Baclofen—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00173	0.00621	CcSEcCtD
Baclofen—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00173	0.0062	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00173	0.00948	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00173	0.00948	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00171	0.00938	CbGpPWpGaD
Baclofen—Drowsiness—Furosemide—dilated cardiomyopathy	0.00171	0.00613	CcSEcCtD
Baclofen—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.0017	0.00609	CcSEcCtD
Baclofen—Renal failure—Furosemide—dilated cardiomyopathy	0.00168	0.00603	CcSEcCtD
Baclofen—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00167	0.00597	CcSEcCtD
Baclofen—Diplopia—Lisinopril—dilated cardiomyopathy	0.00167	0.00597	CcSEcCtD
Baclofen—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00165	0.00592	CcSEcCtD
Baclofen—Sweating—Furosemide—dilated cardiomyopathy	0.00164	0.00588	CcSEcCtD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00162	0.0089	CbGpPWpGaD
Baclofen—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00162	0.0058	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00161	0.00882	CbGpPWpGaD
Baclofen—Face oedema—Lisinopril—dilated cardiomyopathy	0.00161	0.00576	CcSEcCtD
Baclofen—Urticaria—Spironolactone—dilated cardiomyopathy	0.00159	0.00571	CcSEcCtD
Baclofen—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00159	0.00568	CcSEcCtD
Baclofen—Ataxia—Lisinopril—dilated cardiomyopathy	0.00157	0.00561	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00156	0.00854	CbGpPWpGaD
Baclofen—Dehydration—Lisinopril—dilated cardiomyopathy	0.00155	0.00555	CcSEcCtD
Baclofen—GABBR2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00155	0.00847	CbGpPWpGaD
Baclofen—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00152	0.00545	CcSEcCtD
Baclofen—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00152	0.00544	CcSEcCtD
Baclofen—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00151	0.0054	CcSEcCtD
Baclofen—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00151	0.0054	CcSEcCtD
Baclofen—Visual impairment—Furosemide—dilated cardiomyopathy	0.00148	0.00531	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00144	0.00791	CbGpPWpGaD
Baclofen—Influenza—Lisinopril—dilated cardiomyopathy	0.00144	0.00516	CcSEcCtD
Baclofen—Eye disorder—Furosemide—dilated cardiomyopathy	0.00144	0.00515	CcSEcCtD
Baclofen—Tinnitus—Furosemide—dilated cardiomyopathy	0.00143	0.00513	CcSEcCtD
Baclofen—Pruritus—Spironolactone—dilated cardiomyopathy	0.00142	0.00509	CcSEcCtD
Baclofen—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0014	0.00503	CcSEcCtD
Baclofen—Angiopathy—Furosemide—dilated cardiomyopathy	0.00139	0.005	CcSEcCtD
Baclofen—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00137	0.00492	CcSEcCtD
Baclofen—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00137	0.00492	CcSEcCtD
Baclofen—Dysuria—Lisinopril—dilated cardiomyopathy	0.00135	0.00483	CcSEcCtD
Baclofen—Malnutrition—Furosemide—dilated cardiomyopathy	0.00134	0.00479	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00133	0.00729	CbGpPWpGaD
Baclofen—Dizziness—Spironolactone—dilated cardiomyopathy	0.00133	0.00475	CcSEcCtD
Baclofen—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00133	0.00475	CcSEcCtD
Baclofen—Flatulence—Furosemide—dilated cardiomyopathy	0.00132	0.00472	CcSEcCtD
Baclofen—Weight increased—Lisinopril—dilated cardiomyopathy	0.00131	0.0047	CcSEcCtD
Baclofen—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00131	0.00469	CcSEcCtD
Baclofen—Weight decreased—Lisinopril—dilated cardiomyopathy	0.0013	0.00467	CcSEcCtD
Baclofen—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.0013	0.00466	CcSEcCtD
Baclofen—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00129	0.00463	CcSEcCtD
Baclofen—Depression—Lisinopril—dilated cardiomyopathy	0.00128	0.00459	CcSEcCtD
Baclofen—Vomiting—Spironolactone—dilated cardiomyopathy	0.00128	0.00457	CcSEcCtD
Baclofen—Rash—Spironolactone—dilated cardiomyopathy	0.00126	0.00453	CcSEcCtD
Baclofen—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00126	0.00453	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00126	0.00692	CbGpPWpGaD
Baclofen—Renal failure—Lisinopril—dilated cardiomyopathy	0.00126	0.00452	CcSEcCtD
Baclofen—Vision blurred—Furosemide—dilated cardiomyopathy	0.00126	0.00452	CcSEcCtD
Baclofen—Headache—Spironolactone—dilated cardiomyopathy	0.00126	0.0045	CcSEcCtD
Baclofen—Anaemia—Furosemide—dilated cardiomyopathy	0.00124	0.00443	CcSEcCtD
Baclofen—Sweating—Lisinopril—dilated cardiomyopathy	0.00123	0.00441	CcSEcCtD
Baclofen—Agitation—Furosemide—dilated cardiomyopathy	0.00123	0.0044	CcSEcCtD
Baclofen—Haematuria—Lisinopril—dilated cardiomyopathy	0.00122	0.00439	CcSEcCtD
Baclofen—GABBR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00122	0.00669	CbGpPWpGaD
Baclofen—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00121	0.00435	CcSEcCtD
Baclofen—Vertigo—Furosemide—dilated cardiomyopathy	0.0012	0.00431	CcSEcCtD
Baclofen—Nausea—Spironolactone—dilated cardiomyopathy	0.00119	0.00427	CcSEcCtD
Baclofen—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00117	0.00421	CcSEcCtD
Baclofen—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00116	0.00414	CcSEcCtD
Baclofen—Hallucination—Lisinopril—dilated cardiomyopathy	0.00115	0.00411	CcSEcCtD
Baclofen—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.00408	CcSEcCtD
Baclofen—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00114	0.00407	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00113	0.00405	CcSEcCtD
Baclofen—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00113	0.00405	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00112	0.00611	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00112	0.00611	CbGpPWpGaD
Baclofen—Dry mouth—Furosemide—dilated cardiomyopathy	0.00111	0.00399	CcSEcCtD
Baclofen—Confusional state—Furosemide—dilated cardiomyopathy	0.0011	0.00394	CcSEcCtD
Baclofen—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00107	0.00385	CcSEcCtD
Baclofen—Shock—Furosemide—dilated cardiomyopathy	0.00107	0.00385	CcSEcCtD
Baclofen—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00107	0.00384	CcSEcCtD
Baclofen—Flushing—Lisinopril—dilated cardiomyopathy	0.00107	0.00383	CcSEcCtD
Baclofen—Skin disorder—Furosemide—dilated cardiomyopathy	0.00106	0.0038	CcSEcCtD
Baclofen—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00106	0.00378	CcSEcCtD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00105	0.00574	CbGpPWpGaD
Baclofen—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00105	0.00375	CcSEcCtD
Baclofen—Anorexia—Furosemide—dilated cardiomyopathy	0.00104	0.00373	CcSEcCtD
Baclofen—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00104	0.00372	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00104	0.00568	CbGpPWpGaD
Baclofen—Chills—Lisinopril—dilated cardiomyopathy	0.00103	0.00371	CcSEcCtD
Baclofen—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00103	0.00369	CcSEcCtD
Baclofen—Hypotension—Furosemide—dilated cardiomyopathy	0.00102	0.00365	CcSEcCtD
Baclofen—Alopecia—Lisinopril—dilated cardiomyopathy	0.00102	0.00365	CcSEcCtD
Baclofen—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00101	0.00362	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.001	0.0055	CbGpPWpGaD
Baclofen—Malnutrition—Lisinopril—dilated cardiomyopathy	0.001	0.0036	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000997	0.00546	CbGpPWpGaD
Baclofen—Flatulence—Lisinopril—dilated cardiomyopathy	0.000989	0.00354	CcSEcCtD
Baclofen—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000982	0.00352	CcSEcCtD
Baclofen—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00098	0.00351	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000978	0.00536	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000978	0.00536	CbGpPWpGaD
Baclofen—Back pain—Lisinopril—dilated cardiomyopathy	0.00097	0.00348	CcSEcCtD
Baclofen—Somnolence—Furosemide—dilated cardiomyopathy	0.00097	0.00348	CcSEcCtD
Baclofen—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000949	0.0034	CcSEcCtD
Baclofen—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000946	0.00339	CcSEcCtD
Baclofen—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000942	0.00338	CcSEcCtD
Baclofen—Fatigue—Furosemide—dilated cardiomyopathy	0.000941	0.00337	CcSEcCtD
Baclofen—Tremor—Lisinopril—dilated cardiomyopathy	0.00094	0.00337	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000937	0.00513	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—RAF1—dilated cardiomyopathy	0.000936	0.00513	CbGpPWpGaD
Baclofen—Pain—Furosemide—dilated cardiomyopathy	0.000933	0.00334	CcSEcCtD
Baclofen—Constipation—Furosemide—dilated cardiomyopathy	0.000933	0.00334	CcSEcCtD
Baclofen—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000931	0.00334	CcSEcCtD
Baclofen—Anaemia—Lisinopril—dilated cardiomyopathy	0.000927	0.00332	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000909	0.00498	CbGpPWpGaD
Baclofen—Malaise—Lisinopril—dilated cardiomyopathy	0.000905	0.00324	CcSEcCtD
Baclofen—Vertigo—Lisinopril—dilated cardiomyopathy	0.000901	0.00323	CcSEcCtD
Baclofen—Syncope—Lisinopril—dilated cardiomyopathy	0.0009	0.00322	CcSEcCtD
Baclofen—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000899	0.00322	CcSEcCtD
Baclofen—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000892	0.0032	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000888	0.00487	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000888	0.00487	CbGpPWpGaD
Baclofen—Palpitations—Lisinopril—dilated cardiomyopathy	0.000887	0.00318	CcSEcCtD
Baclofen—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000882	0.00316	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000881	0.00483	CbGpPWpGaD
Baclofen—Urticaria—Furosemide—dilated cardiomyopathy	0.000867	0.00311	CcSEcCtD
Baclofen—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000863	0.00309	CcSEcCtD
Baclofen—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000863	0.00309	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000858	0.0047	CbGpPWpGaD
Baclofen—Chest pain—Lisinopril—dilated cardiomyopathy	0.000854	0.00306	CcSEcCtD
Baclofen—Myalgia—Lisinopril—dilated cardiomyopathy	0.000854	0.00306	CcSEcCtD
Baclofen—Anxiety—Lisinopril—dilated cardiomyopathy	0.000851	0.00305	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000848	0.00304	CcSEcCtD
Baclofen—Discomfort—Lisinopril—dilated cardiomyopathy	0.000844	0.00302	CcSEcCtD
Baclofen—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000835	0.00299	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000826	0.00452	CbGpPWpGaD
Baclofen—Confusional state—Lisinopril—dilated cardiomyopathy	0.000826	0.00296	CcSEcCtD
Baclofen—Oedema—Lisinopril—dilated cardiomyopathy	0.000819	0.00293	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000814	0.00446	CbGpPWpGaD
Baclofen—Infection—Lisinopril—dilated cardiomyopathy	0.000813	0.00292	CcSEcCtD
Baclofen—Shock—Lisinopril—dilated cardiomyopathy	0.000806	0.00289	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0008	0.00438	CbGpPWpGaD
Baclofen—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000799	0.00286	CcSEcCtD
Baclofen—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000795	0.00285	CcSEcCtD
Baclofen—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000792	0.00284	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000787	0.00431	CbGpPWpGaD
Baclofen—Asthenia—Furosemide—dilated cardiomyopathy	0.000783	0.00281	CcSEcCtD
Baclofen—Anorexia—Lisinopril—dilated cardiomyopathy	0.000781	0.0028	CcSEcCtD
Baclofen—Pruritus—Furosemide—dilated cardiomyopathy	0.000772	0.00277	CcSEcCtD
Baclofen—Hypotension—Lisinopril—dilated cardiomyopathy	0.000765	0.00274	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000755	0.00413	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000752	0.00412	CbGpPWpGaD
Baclofen—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000747	0.00268	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000746	0.00267	CcSEcCtD
Baclofen—Insomnia—Lisinopril—dilated cardiomyopathy	0.000741	0.00265	CcSEcCtD
Baclofen—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000735	0.00264	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000734	0.00402	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000734	0.00402	CbGpPWpGaD
Baclofen—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00073	0.00262	CcSEcCtD
Baclofen—Somnolence—Lisinopril—dilated cardiomyopathy	0.000728	0.00261	CcSEcCtD
Baclofen—Dizziness—Furosemide—dilated cardiomyopathy	0.000722	0.00259	CcSEcCtD
Baclofen—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000721	0.00258	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000714	0.00391	CbGpPWpGaD
Baclofen—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000712	0.00255	CcSEcCtD
Baclofen—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000707	0.00253	CcSEcCtD
Baclofen—Fatigue—Lisinopril—dilated cardiomyopathy	0.000706	0.00253	CcSEcCtD
Baclofen—Constipation—Lisinopril—dilated cardiomyopathy	0.0007	0.00251	CcSEcCtD
Baclofen—Pain—Lisinopril—dilated cardiomyopathy	0.0007	0.00251	CcSEcCtD
Baclofen—Vomiting—Furosemide—dilated cardiomyopathy	0.000694	0.00249	CcSEcCtD
Baclofen—Rash—Furosemide—dilated cardiomyopathy	0.000688	0.00247	CcSEcCtD
Baclofen—Dermatitis—Furosemide—dilated cardiomyopathy	0.000687	0.00246	CcSEcCtD
Baclofen—Headache—Furosemide—dilated cardiomyopathy	0.000684	0.00245	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000683	0.00374	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000683	0.00374	CbGpPWpGaD
Baclofen—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000675	0.00242	CcSEcCtD
Baclofen—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00067	0.0024	CcSEcCtD
Baclofen—Urticaria—Lisinopril—dilated cardiomyopathy	0.00065	0.00233	CcSEcCtD
Baclofen—Nausea—Furosemide—dilated cardiomyopathy	0.000648	0.00232	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000648	0.00355	CbGpPWpGaD
Baclofen—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000647	0.00232	CcSEcCtD
Baclofen—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000647	0.00232	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00063	0.00345	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00063	0.00345	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000604	0.00331	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—RAF1—dilated cardiomyopathy	0.000603	0.0033	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000591	0.00324	CbGpPWpGaD
Baclofen—Asthenia—Lisinopril—dilated cardiomyopathy	0.000587	0.00211	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000586	0.00321	CbGpPWpGaD
Baclofen—Pruritus—Lisinopril—dilated cardiomyopathy	0.000579	0.00208	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000572	0.00314	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000572	0.00314	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000568	0.00311	CbGpPWpGaD
Baclofen—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00056	0.00201	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000554	0.00304	CbGpPWpGaD
Baclofen—Dizziness—Lisinopril—dilated cardiomyopathy	0.000541	0.00194	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000532	0.00292	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000529	0.0029	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000525	0.00287	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000525	0.00287	CbGpPWpGaD
Baclofen—Vomiting—Lisinopril—dilated cardiomyopathy	0.000521	0.00187	CcSEcCtD
Baclofen—Rash—Lisinopril—dilated cardiomyopathy	0.000516	0.00185	CcSEcCtD
Baclofen—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000516	0.00185	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000515	0.00282	CbGpPWpGaD
Baclofen—Headache—Lisinopril—dilated cardiomyopathy	0.000513	0.00184	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000503	0.00276	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000488	0.00267	CbGpPWpGaD
Baclofen—Nausea—Lisinopril—dilated cardiomyopathy	0.000486	0.00174	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000485	0.00266	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000481	0.00263	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000473	0.00259	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00046	0.00252	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00044	0.00241	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000418	0.00229	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000404	0.00221	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000383	0.0021	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000381	0.00209	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000357	0.00196	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000341	0.00187	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000338	0.00185	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000338	0.00185	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000334	0.00183	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000329	0.0018	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000324	0.00178	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000314	0.00172	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00031	0.0017	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000304	0.00167	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000297	0.00163	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000284	0.00156	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00026	0.00142	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000247	0.00135	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000229	0.00125	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000215	0.00118	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000212	0.00116	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000197	0.00108	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000192	0.00105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000183	0.001	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000149	0.000816	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000147	0.000808	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000135	0.00074	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000127	0.000696	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.71e-05	0.000477	CbGpPWpGaD
